3Parsa CJ,Koch WJ.Gene interventions in the bata-adrenergic system for treating heart failure[J].Semin Thorac Cardiovasc Surg,2003,15(3):259-267.
4Maurice JP,Hata JA,Shah AS,et al.Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery[J].Clin lnvest,1999,104(1):21-29.
5Williams ML,Hata JA,Schroder J,et al.Targeted beta-adrenengic receptor kinase(betaARKl)inhibition by gene transfer in failing human hearts[J].Circulation,2004,109(13):1590-1593.
6Bemecker OY,Monte F,Hajjar RJ.Gene therapy for the treatment of heart failure-calcium signaling[J].Semin Thorac Cardiovasc Surg,2003,15(3):267-276.
8Huq F,Lebeche D,LyerV,et al.Gene transfer of parvalbumin improves diastolic dysfunction in senescent myocytes[J].Circulation,2004,109(22):2780-2785.
9Leotta E,Pateiunas G,Murphy G,et al.Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac pertormance in a pacing model of congestive heart failure[J].JThorac Cardiovasc Surg,2002,126(6):1101-1103.
10Jin H,Wyss JM,Yang R,et al.The therapeutic potential of hepatocyte growth factor for myocardial infrarction and heaet failure[J].Curr Pharm Des,2004,10(20):2525～2533.
